A new hope in the treatment of coronary vasospasm: bosentan. | Turk Kardiyol Dern Ars;41(7): 633-7, 2013 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

A new hope in the treatment of coronary vasospasm: bosentan.

Gül, Ilker; Aykan, Ahmet Cagri; Gökdeniz, Tayyar; Celik, Sükrü.

Affiliation

Gül I; Department of Cardiology, Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon, Turkey. drilkergul@gmail.com.

Turk Kardiyol Dern Ars ; 41(7): 633-7, 2013 Oct.

Article in En | MEDLINE | ID: mdl-24164996

Subject(s)

Coronary Vasospasm/drug therapy; Endothelin Receptor Antagonists/therapeutic use; Sulfonamides/therapeutic use; Aged; Bosentan; Coronary Vasospasm/diagnosis; Coronary Vasospasm/physiopathology; Humans; Male

Search on Google

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Coronary Vasospasm / Endothelin Receptor Antagonists Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Year: 2013 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Coronary Vasospasm / Endothelin Receptor Antagonists Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Year: 2013 Type: Article